M
MoonLake Immunotherapeutics D
D
MLTX
54.330
USD
2.30
(4.42%)
Market Closed
Volume
5,283
EPS
-2
Div Yield
-
P/E
-43
Market Cap
3,426,263,263
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: MoonLake Immunotherapeutics
Sector: Healthcare
Industry: Biotechnology
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.